Company
Stoke Therapeutics
Restoring protein expression by harnessing the body’s potential with RNA medicine.
Also known as Stoke Therapeutics, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Founded
- 2014
- Legal name
- Stoke Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
We are united in our mission to address the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines.
Funding snapshot
- Total raised
- $90.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $90M2018-10-22
Funding rounds
- Round, 2018
- $90M2018-10-22, SEC form D sold, 14 investors
- Round, 2014
- $850K2014-11-13, SEC form D sold, 1 investor
Loading relationship preview